Detection of autoantibodies to desmoplakin in a patient with oral erythema multiforme

European Journal of Dermatology

Volumn 17, Issue 3, 2007, Pages 238-241

  Fukiwake, Noriko ^a   Moroi, Yoichi ^a   Urabe, Kazunori ^a   Ishii, Norito ^b   Hashimoto, Takashi ^b   Furue, Masutaka ^a  

^a KYUSHU UNIVERSITY HOSPITAL   (Japan)

^b KURUME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Antoantibody; Desmoplakin; Erythema multiforme; Immunoblotting

Indexed keywords

AUTOANTIBODY; DESMOPLAKIN; DESMOPLAKIN 1 ANTIBODY; DESMOPLAKIN 2 ANTIBODY; UNCLASSIFIED DRUG;

AGED; ANAMNESIS; ARTICLE; AUTOIMMUNE DISEASE; CASE REPORT; CLINICAL FEATURE; DESMOSOME; ENZYME LINKED IMMUNOSORBENT ASSAY; ERYTHEMA MULTIFORME; FEMALE; HUMAN; IMMUNOBLOTTING; IMMUNOFLUORESCENCE; PEMPHIGUS;

AGED; AUTOANTIBODIES; DESMOPLAKINS; ERYTHEMA MULTIFORME; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; HUMANS; IMMUNOBLOTTING; MOUTH MUCOSA;

EID: 34249795148     PISSN: 11671122     EISSN: None     Source Type: Journal    
DOI: 10.1684/ejd.2007.0157     Document Type: Article

References (23)

1. Hashimoto T, Amagai M, Garrod DR, Nishikawa T. Immunofluorescence and immunoblot studies on the reactivity of pemphigus vulgaris and pemphigus foliaceus sera with desmoglein 3 and desmoglein 1. Epithelial Cell Biol 1995; 4: 63-9.
2. Anhalt GJ, Labib RS, Voorhees JJ, Beals TF, Diaz LA. Induction of pemphigus in neonatal mice by passive transfer of IgG from patients with the disease. N Engl J Med 1982; 306: 1189-96.
3. Zillikens D. Acquired skin disease of hemidesmosomes. J Dermatol Sci 1999; 20: 134-54; (Review).
4. Labib RS, Anhalt GJ, Patel HP, Mutasim DF, Diaz LA. Molecular heterogeneity of the bullous pemphigoid antigens as detected by immunoblotting. J Immunol 1986; 136: 1231-5.
5. Stanley JR, Hawley-Nelson P, Yuspa SH, Shevach EM, Katz SI. Characterization of bullous pemphigoid antigen: a unique basement membrane protein of stratified squamous epithelia. Cell 1981; 24: 897-903.
6. Hashimoto T. Recent advances in the study of the pathophysiology of pemphigus. Arch Dermatol Res 2003; 295(Suppl 1): S2-S11; (Review).
7. Anhalt GJ, Kim SC, Stanley JR, Korman NJ, Jabs DA, Kory M, Izumi H, Ratríe 3rd H, Mutasim D, Ariss-Abdo L, et al. Paraneoplastic pemphigus. An autoimmune mucocutaneous disease associated with neoplasia. N Engl J Med 1990; 323: 1729-35.
8. Foedinger D, Sterniczky B, Elbe A, Anhalt G, Wolff K, Rappersberger K. Autoantibodies against desmoplakin I and II define a subset of patients with erythema multiforme major. J Invest Dermatol 1996; 106: 1012-6.
9. Huff JC, Weston WL, Tonnesen MG. Erythema multiforme: a critical review of characteristics, diagnostic criteria,and causes. J Am Acad Dermatol 1983; 8: 763-75; (Review).
10. Bean SF, Quezada RK. Recurrent oral erythema multiforme. Clinical experience with 11 patients. JAMA 1983; 249: 2810-2.
11. Gebel K, Hornstein OP. Drug-induced oral erythema multiforme. Results of a long-term retrospectivestudy. Dermatologica 1984; 168: 35-40.
12. Nesbit SP, Gobetti JP. Multiple recurrence of oral erythema multiforme after secondary herpes simplex: report of case and review of literature. J Am Dent Assoc 1986; 112: 348-52.
13. Lozada-Nur F, Gorsky M, Silverman Jr. S. Oral erythema multiforme: clinical observations and treatment of 95 patients. Oral Surg Oral Med Oral Pathol 1989; 67: 36-40.
14. Ayangco L, Rogers 3rd RS. Oral manifestations of erythema multiforme. Dermatol Clin 2003; 21: 195-205; (Review).
15. Eisen D. The therapy of oral lichen planus. Crit Rev Oral Biol Med 1993; 4: 141-58; (Review).
16. Lodi G, Scully C, Carrozzo M, Griffiths M, Sugerman PB, Thongprasom K. Current controversies in oral lichen planus: report of an international consensus meeting. Part 1. Viral infections and etiopathogenesis. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2005; 100: 40-51.
17. Eisenberg E. Oral lichen planus: a benign lesion. J Oral Maxillofac Surg 2000; 58: 1278-85; (Review).
18. Jaremko WM, Beutner EH, Kumar V, Kipping H, Condry P, Zeid MY, Kauffmann CL, Tatakis DN, Chorzelski TP. Chronic ulcerative stomatitis associated with a specific immunologic marker. J Am Acad Dermatol 1990; 22: 215-20.
19. Hashimoto T, Watanabe K, Ishiko A, Shimizu H, Hanyaku H, Kimura S, Nishikawa T. A case of bullous pemphigoid with antidesmoplakin autoantibodies. Br J Dermatol 1994; 131: 694-9.
20. Jiao D, Bystryn JC. Antibodies to desmoplakin in a patient with pemphigus foliaceous. J Eur Acad Dermatol Venereol 1998; 11: 169-72.
21. Mimouni D, Foedinger D, Kouba DJ, Orlow SJ, Rappersberger K, Sciubba JJ, Nikolskaia OV, Cohen BA, Anhalt GJ, Nousari CH. Mucosal dominant pemphigus vulgaris with anti-desmoplakin autoantibodies. J Am Acad Dermatol 2004; 51: 62-7.
22. Oyama N, Setterfield JF, Gratian MJ, Bhogal BS, Shirlaw P, Challacombe SJ, Black MM. Oral and genital lichenoid reactions associated with circulating autoantibodies to desmoplakins I and II: a novel target antigen or example of epitope spreading? J Am Acad Dermatol 2003; 48: 433-8.
23. Foedinger D, Elbe-Burger A, Sterniczky B, Lackner M, Horvat R, Wolff K, Rappersberger K. Erythema multiforme associated human autoantibodies against desmoplakin I and II: biochemical characterization and passive transfer studies into newborn mice. J Invest Dermatol 1998; 111: 503-10.